missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ C. botulinum BoNT-A Light Chain Polyclonal Antibody

Description
In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant C. botulinum BoNTA Heavy Chain is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Botulinum neurotoxin type A is one of the seven serotypes of Botulinum Neurotoxins (BoNTs) produced by various strains of Clostridium botulinum. BoNTs are synthesized as inactive single chain protein precursors and activated by proteolytic cleavage to generate disulfide-linked two-chain proteins. The 50 kDa light chain contains the catalytic domain, whereas the 100 kDa heavy chain contains an internal translocation domain and a receptor binding domain. BoNTs are the most potent protein toxins for humans. As zinc proteases, they cleave SNARE proteins to elicit flaccid paralysis in botulism by blocking acetylcholine release at the neuromuscular junction. E. coli-expressed recombinant light chains are active proteases. However, they are not toxic because they cannot enter into host cells in the absence of the heavy chains.
Specifications
Specifications
| Antigen | C. botulinum BoNT-A Light Chain |
| Applications | Immunoprecipitation, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene Alias | BONTC1 |
| Host Species | Sheep |
| Immunogen | E. coli-derived recombinant Clostridium BoNT-A Light Chain Met1-Phe425. |
| Purification Method | Antigen affinity chromatography |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?